TCG Crossover Management, LLC Diversified Active

Location: Palo Alto, CA

CIK: 0001839948 · Show all filings

Period: Q2 2023 (← Previous) (Next →)

Filing Date: Aug 14, 2023

Total Value: $610M (100.0% shares, 0.0% debt)

Holdings (22)

— IVERIC BIO INC 15.8%
Value $96.34M Shares 2,448,829 Share Price $39.34 Est. Cost/Share $17.57 Unrealized @ Report Date —
GERN GERON CORP 12.4%
Value $75.72M Shares 23,589,779 Share Price $3.21 * Est. Cost/Share $1.89 Unrealized @ Report Date +50.9%
COGT COGENT BIOSCIENCES INC 10.9%
Value $66.67M Shares 5,631,042 Share Price $11.84 * Est. Cost/Share $9.54 Unrealized @ Report Date +20.2%
— VECTIVBIO HOLDING AG 8.7%
Value $52.93M Shares 3,113,600 Share Price $17.00 Est. Cost/Share $8.63 Unrealized @ Report Date —
— AEROVATE THERAPEUTICS INC 6.2%
Value $37.75M Shares 2,201,274 Share Price $17.15 Est. Cost/Share $15.75 Unrealized @ Report Date —
— ICOSAVAC, INC 6.0%
Value $36.78M Shares 3,703,704 Share Price $9.93 Est. Cost/Share $9.93 Unrealized @ Report Date —
MDGL MADRIGAL PHARMACEUTICALS INC 5.7%
Value $34.63M Shares 149,917 Share Price $231.00 * Est. Cost/Share $94.85 Unrealized @ Report Date +185.5%
TYRA TYRA BIOSCIENCES INC 5.6%
Value $33.87M Shares 1,989,103 Share Price $17.03 * Est. Cost/Share $12.71 Unrealized @ Report Date +14.2%
KALV KALVISTA PHARMACEUTICALS, INC 5.0%
Value $30.56M Shares 3,395,495 Share Price $9.00 * Est. Cost/Share $5.36 Unrealized @ Report Date +72.1%
VTYX VENTYX BIOSCIENCES, INC 4.4%
Value $26.76M Shares 815,724 Share Price $32.80 * Est. Cost/Share $29.94 Unrealized @ Report Date +15.1%
DYN DYNE THERAPEUTICS, INC 3.0%
Value $18.56M Shares 1,650,150 Share Price $11.25 * Est. Cost/Share $12.99 Unrealized @ Report Date -9.2%
KURA KURA ONCOLOGY INC 2.5%
Value $15.06M Shares 1,423,642 Share Price $10.58 * Est. Cost/Share $14.54 Unrealized @ Report Date -18.7%
GPCR STRUCTURE THERAPEUTICS INC 2.4%
Value $14.55M Shares 350,000 Share Price $41.57 Est. Cost/Share $23.79 Unrealized @ Report Date —
IMVT IMMUNOVANT, INC 2.0%
Value $12.42M Shares 654,853 Share Price $18.97 Est. Cost/Share $12.59 Unrealized @ Report Date +48.1%
SLN SILENCE THERAPEUTICS PLC 1.9%
Value $11.58M Shares 2,104,875 Share Price $5.50 Est. Cost/Share $10.03 Unrealized @ Report Date —
ANTX AN2 Therapeutics, Inc. 1.8%
Value $10.96M Shares 1,289,320 Share Price $8.50 * Est. Cost/Share $7.19 Unrealized @ Report Date 0.0%
TRDA ENTRADA THERAPEUTICS INC 1.5%
Value $8.856M Shares 584,955 Share Price $15.14 Est. Cost/Share $17.12 Unrealized @ Report Date —
— MERUS BV 1.3%
Value $7.899M Shares 300,000 Share Price $26.33 Est. Cost/Share $30.46 Unrealized @ Report Date —
CABA CABALETTA BIO, INC 1.0%
Value $6.285M Shares 486,795 Share Price $12.91 * Est. Cost/Share $3.64 Unrealized @ Report Date +198.1%
ACRS ACLARIS THERAPEUTICS INC 0.9%
Value $5.494M Shares 529,839 Share Price $10.37 * Est. Cost/Share $15.07 Unrealized @ Report Date -39.9%
CCCC C4 THERAPEUTICS, INC. 0.6%
Value $3.511M Shares 1,276,574 Share Price $2.75 * Est. Cost/Share $5.83 Unrealized @ Report Date -44.9%
— ALPINE IMMUNE SCIENCES INC 0.4%
Value $2.602M Shares 253,069 Share Price $10.28 Est. Cost/Share $13.85 Unrealized @ Report Date —